Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Stimulates maximum collagen
In Usp2 KO TECs, there is less TGFBR1 protein when compared to those in WT TECs under TGF-1 stimulation (Fig
Completed Phase II and III clinical trials have indicated that the agent has a nonoverlapping toxicity profile and synergistic effects with carboplatin, paclitaxel, and anthracycline, has no cross-drug resistance and is well tolerated, with patients mostly reporting fatigue and nausea
Biomarkers for assessing neurocognitive effects vary depending on the neuropeptide and the experimental model used
It is recommended for women planning pregnancy to start at least one month before conception and continue through pregnancy
We review candidacy, risks, and medication interactions during consultation
US$ 23.08
US$ 24.64
US$ 24.65
US$ 22.19
US$ 25.87
